Edition:
United States

People: Ablynx NV (ABLX.BR)

ABLX.BR on Brussels Stock Exchange

11.75EUR
23 Sep 2016
Change (% chg)

€0.06 (+0.56%)
Prev Close
€11.69
Open
€11.62
Day's High
€11.83
Day's Low
€11.50
Volume
177,480
Avg. Vol
214,383
52-wk High
€16.20
52-wk Low
€10.00

Jenkins, William 

Dr. William J. Jenkins, M.D., is Independent Director of Ablynx NV. He is Principal of William Jenkins Pharma Consulting and has been advising a wide range of pharma and biotech companies, and investment and venture capital firms in the healthcare sector since 1999. Formerly, he was Head of Worldwide Clinical and Regulatory Affairs for Novartis Pharma and held a similar position with Glaxo Group Research Limited. He is currently Senior independent Director of Consort Medical, a member of the Board of Allecra Therapeutics AG and of Allocyte Pharmaceuticals AG, and a member of the Strategic Advisory Board of Chiesi Farmaceutici. In addition, he is a member of the Scientific Advisory Boards of BB Biotech Ventures II and III funds, and until recently of Nicholas Piramal India.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --